Q1 2016 13F Holders as of 31 Mar 2016
-
Type / Class
-
Equity / COM PAR
-
Number of holders
-
20
-
Total 13F shares, excl. options
-
918,242
-
Shares change
-
+606,261
-
Total reported value, excl. options
-
$6,287,000
-
Value change
-
+$4,141,484
-
Number of buys
-
15
-
Number of sells
-
-1
-
Price
-
$6.85
Significant Holders of IMMUCELL CORP /DE/ - COM PAR (ICCC) as of Q1 2016
21 filings reported holding ICCC - IMMUCELL CORP /DE/ - COM PAR as of Q1 2016.
IMMUCELL CORP /DE/ - COM PAR (ICCC) has 20 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 918,242 shares
.
Largest 10 shareholders include NORTHPOINTE CAPITAL LLC (255,309 shares), HEARTLAND ADVISORS INC (203,100 shares), HealthInvest Partners AB (168,323 shares), PERRITT CAPITAL MANAGEMENT INC (82,579 shares), RENAISSANCE TECHNOLOGIES LLC (56,707 shares), SHUFRO ROSE & CO LLC (42,191 shares), MORGAN STANLEY (35,555 shares), Essex Financial Services, Inc. (23,776 shares), VANGUARD GROUP INC (22,375 shares), and Minerva Advisors LLC (14,559 shares).
This table shows the top 20 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.